Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Shaw

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
BMC Pediatrics|April 18, 2015
Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United StatesGloria S Pryhuber, Nathalie L Maitre, Roberta A Ballard, et al.
Critical Care Medicine|September 16, 2016
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic LeukemiaJulie C Fitzgerald, Scott L Weiss, Shannon L Maude, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|January 5, 2012
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALSMarkus Otto, Robert Bowser, Martin Turner, et al.
Annals of the New York Academy of Sciences|May 21, 2024
Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosisHugo Alarcan, Clément Bruno, Patrick Emond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune CellsRaghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster, et al.
Nature Medicine|April 8, 2015
Studying clonal dynamics in response to cancer therapy using high-complexity barcodingHyo-eun C Bhang, David A Ruddy, Viveksagar Krishnamurthy Radhakrishna, et al.
Research Square|June 12, 2026
Single-nucleus multiomic atlas of ALS primary motor cortex nominates neuroprotective WDR49-expressing astrocytesJohnathan Cooper-Knock, Sam Bonsall, Rodrigo Kazu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Real-world prognostic role of riluzole use in ALS: a multi-center study from PRECISION-ALSRosario Vasta, Fouke Ombelet, Frederik Hobin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Clinical trajectories of genetic variants in ALS: a European observational study within PRECISION-ALSRobert McFarlane, Sarah Opie-Martin, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Mapping the natural history of amyotrophic lateral sclerosis: time-to-event analysis of clinical milestones in the pan-European, population-based PRECISION-ALS cohortAlejandro Caravaca Puchades, Harry E McDonough, Ammar Al-Chalabi, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
BMC Pediatrics|April 18, 2015
Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United StatesGloria S Pryhuber, Nathalie L Maitre, Roberta A Ballard, et al.
Critical Care Medicine|September 16, 2016
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic LeukemiaJulie C Fitzgerald, Scott L Weiss, Shannon L Maude, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|January 5, 2012
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALSMarkus Otto, Robert Bowser, Martin Turner, et al.
Annals of the New York Academy of Sciences|May 21, 2024
Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosisHugo Alarcan, Clément Bruno, Patrick Emond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune CellsRaghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster, et al.
Nature Medicine|April 8, 2015
Studying clonal dynamics in response to cancer therapy using high-complexity barcodingHyo-eun C Bhang, David A Ruddy, Viveksagar Krishnamurthy Radhakrishna, et al.
Research Square|June 12, 2026
Single-nucleus multiomic atlas of ALS primary motor cortex nominates neuroprotective WDR49-expressing astrocytesJohnathan Cooper-Knock, Sam Bonsall, Rodrigo Kazu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Real-world prognostic role of riluzole use in ALS: a multi-center study from PRECISION-ALSRosario Vasta, Fouke Ombelet, Frederik Hobin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Clinical trajectories of genetic variants in ALS: a European observational study within PRECISION-ALSRobert McFarlane, Sarah Opie-Martin, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Mapping the natural history of amyotrophic lateral sclerosis: time-to-event analysis of clinical milestones in the pan-European, population-based PRECISION-ALS cohortAlejandro Caravaca Puchades, Harry E McDonough, Ammar Al-Chalabi, et al.
Pageof 6